雌酮3-硫酸钠盐结构式
|
常用名 | 雌酮3-硫酸钠盐 | 英文名 | Estrone sulfate sodium |
|---|---|---|---|---|
| CAS号 | 438-67-5 | 分子量 | 372.41 | |
| 密度 | 1.349 g/cm3 | 沸点 | N/A | |
| 分子式 | C18H21NaO5S | 熔点 | 258-260°C | |
| MSDS | 中文版 美版 | 闪点 | N/A | |
| 符号 |
GHS07, GHS08 |
信号词 | Danger |
雌酮3-硫酸钠盐用途雌酮硫酸盐是一种生物活性雌激素,是一种主要的循环血浆雌激素,通过类固醇硫酸酯酶(STS)转化为生物活性雌激素雌酮(E1)。硫酸锶可用于乳腺癌的研究[1][2]。 |
| 中文名 | 雌酮3-硫酸钠 |
|---|---|
| 英文名 | estrone sodium sulfate |
| 中文别名 | 3-硫酸雌酮钠盐 | 雌酮硫酸钠 | 雌酮 3-硫酸酯钠盐 |
| 英文别名 | 更多 |
| 描述 | 雌酮硫酸盐是一种生物活性雌激素,是一种主要的循环血浆雌激素,通过类固醇硫酸酯酶(STS)转化为生物活性雌激素雌酮(E1)。硫酸锶可用于乳腺癌的研究[1][2]。 |
|---|---|
| 相关类别 | |
| 靶点 |
Human Endogenous Metabolite |
| 体外研究 | 用SOAT稳定转染T47D细胞,并在生理相关浓度下增加硫酸雌酮和雌二醇浓度进行培养。1 nM雌二醇和EC50为2.2 nM的硫酸雌酮可显著增加细胞增殖[3]。 |
| 参考文献 |
| 密度 | 1.349 g/cm3 |
|---|---|
| 熔点 | 258-260°C |
| 分子式 | C18H21NaO5S |
| 分子量 | 372.41 |
| 精确质量 | 372.100739 |
| PSA | 91.88000 |
| LogP | 4.03160 |
| 储存条件 | -20°C |
| 符号 |
GHS07, GHS08 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H315-H319-H335-H350 |
| 警示性声明 | P201-P261-P305 + P351 + P338-P308 + P313 |
| 危害码 (欧洲) | T: Toxic; |
| 风险声明 (欧洲) | R45-36/37/38 |
| 安全声明 (欧洲) | S53-45-26 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
| RTECS号 | KG8775000 |
| 雌酮3-硫酸钠盐上游产品 2 | |
|---|---|
| 雌酮3-硫酸钠盐下游产品 1 | |
|
Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions.
J. Pharm. Sci. 102(1) , 280-8, (2013) We aimed to explore the major active components in grapefruit juice (GFJ), orange juice (OJ), and apple juice (AJ) that are responsible for OATP2B1-mediated drug interactions, by means of in vitro stu... |
|
|
Quantitative transporter proteomics by liquid chromatography with tandem mass spectrometry: addressing methodologic issues of plasma membrane isolation and expression-activity relationship.
Drug Metab. Dispos. 43(2) , 284-8, (2015) To predict transporter-mediated drug disposition using physiologically based pharmacokinetic models, one approach is to measure transport activity and relate it to protein expression levels in cell li... |
|
|
Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.
J. Clin. Oncol. 32(28) , 3111-7, (2014) Endogenous hormones are risk factors for postmenopausal breast cancer, and their measurement may improve our ability to identify high-risk women. Therefore, we evaluated whether inclusion of plasma es... |
| Estra-1(10),2,4-trien-17-one, 3-(sulfooxy)-, sodium salt (1:1) |
| Sodium 17-oxoestra-1(10),2,4-trien-3-yl sulfate |
| Estrone 3-sulfate sodium salt |
| Estrone sodium sulfate |
| Estrone sulfate sodium |
| Estrone-3-sulfate sodium salt |
| estrone sodium sulphate |
| Sodium estrone 3-sulfate |